The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent

N. Stern; A. Teicher; T. Rosenthal

doi:10.1002/clc.4960050202

The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent

N. Stern, A. Teicher, T. Rosenthal^*

^*Corresponding author for this work

Clinical Departments

Research output: Contribution to journal › Article › peer-review

Abstract

Summary: A new alpha‐ and beta‐blocking agent, labetalol, was used to treat 50 hypertensive patients, 34 of them with refractory hypertension. A significant reduction in hypertension was achieved with relatively few adverse reactions. The combination of alpha and beta blockers in labetalol with their mutually opposing characteristics offers an interesting and promising approach to the control of hypertension.

Original language	English
Pages (from-to)	125-130
Number of pages	6
Journal	Clinical Cardiology
Volume	5
Issue number	2
DOIs	https://doi.org/10.1002/clc.4960050202
State	Published - Feb 1982

Keywords

Hypertension
labetalol alpha‐ and beta‐blocking agent

Access to Document

10.1002/clc.4960050202

Cite this

@article{fe9aaa92ae0640f1b2f427bd005e1329,

title = "The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent",

abstract = "Summary: A new alpha‐ and beta‐blocking agent, labetalol, was used to treat 50 hypertensive patients, 34 of them with refractory hypertension. A significant reduction in hypertension was achieved with relatively few adverse reactions. The combination of alpha and beta blockers in labetalol with their mutually opposing characteristics offers an interesting and promising approach to the control of hypertension.",

keywords = "Hypertension, labetalol alpha‐ and beta‐blocking agent",

author = "N. Stern and A. Teicher and T. Rosenthal",

year = "1982",

month = feb,

doi = "10.1002/clc.4960050202",

language = "אנגלית",

volume = "5",

pages = "125--130",

journal = "Clinical Cardiology",

issn = "0160-9289",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent

AU - Stern, N.

AU - Teicher, A.

AU - Rosenthal, T.

PY - 1982/2

Y1 - 1982/2

N2 - Summary: A new alpha‐ and beta‐blocking agent, labetalol, was used to treat 50 hypertensive patients, 34 of them with refractory hypertension. A significant reduction in hypertension was achieved with relatively few adverse reactions. The combination of alpha and beta blockers in labetalol with their mutually opposing characteristics offers an interesting and promising approach to the control of hypertension.

AB - Summary: A new alpha‐ and beta‐blocking agent, labetalol, was used to treat 50 hypertensive patients, 34 of them with refractory hypertension. A significant reduction in hypertension was achieved with relatively few adverse reactions. The combination of alpha and beta blockers in labetalol with their mutually opposing characteristics offers an interesting and promising approach to the control of hypertension.

KW - Hypertension

KW - labetalol alpha‐ and beta‐blocking agent

UR - http://www.scopus.com/inward/record.url?scp=0019904666&partnerID=8YFLogxK

U2 - 10.1002/clc.4960050202

DO - 10.1002/clc.4960050202

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 7039899

AN - SCOPUS:0019904666

SN - 0160-9289

VL - 5

SP - 125

EP - 130

JO - Clinical Cardiology

JF - Clinical Cardiology

IS - 2

ER -

The treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this